BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 217 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $348,902,000 | -21.2% | 2,308,014 | -24.1% | 0.86% | -14.8% |
Q2 2022 | $442,826,000 | +1865.7% | 3,039,092 | +1499.5% | 1.02% | +2260.5% |
Q1 2022 | $22,528,000 | +42.2% | 190,000 | +65.2% | 0.04% | +48.3% |
Q4 2021 | $15,848,000 | +90.1% | 115,000 | +91.7% | 0.03% | +81.2% |
Q3 2021 | $8,335,000 | +74.2% | 60,000 | -14.3% | 0.02% | +60.0% |
Q1 2021 | $4,785,000 | -62.8% | 70,000 | -53.3% | 0.01% | -64.3% |
Q4 2020 | $12,857,000 | -56.1% | 150,000 | -66.7% | 0.03% | -61.6% |
Q3 2020 | $29,255,000 | +100.1% | 450,000 | +125.0% | 0.07% | +97.3% |
Q2 2020 | $14,622,000 | +118.1% | 200,000 | +1.5% | 0.04% | +85.0% |
Q1 2020 | $6,703,000 | -86.3% | 196,975 | -78.1% | 0.02% | -83.3% |
Q4 2019 | $48,996,000 | -25.4% | 900,000 | -42.9% | 0.12% | -25.5% |
Q3 2019 | $65,709,000 | +17.7% | 1,575,000 | +23.5% | 0.16% | +15.8% |
Q2 2019 | $55,832,000 | +60.7% | 1,275,000 | +88.9% | 0.14% | +59.8% |
Q1 2019 | $34,742,000 | +87.9% | 675,000 | +35.0% | 0.09% | +70.6% |
Q4 2018 | $18,490,000 | – | 500,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |